Average Co-Inventor Count = 6.42
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Relypsa, Inc. (17 from 32 patents)
2. Tricida, Inc. (10 from 11 patents)
3. Ilypsa, Inc. (9 from 12 patents)
4. International Business Machines Corporation (2 from 164,197 patents)
5. Arcus Biosciences, Inc. (2 from 36 patents)
6. Vifor (international) Ltd. (2 from 9 patents)
7. Renosis, Inc. (2 from 3 patents)
8. Dow Global Technolgoies LLC (1 from 4,642 patents)
44 patents:
1. 12281136 - Crystalline forms of a CD73 inhibitor and uses thereof
2. 11992501 - Compositions for and methods of treating acid-base disorders
3. 11738041 - Proton-binding polymers for oral administration
4. 11649261 - Crystalline forms of a CD73 inhibitor and uses thereof
5. 11406661 - HCl-binding compositions for and methods of treating acid-base disorders
6. 11311571 - Proton-binding polymers for oral administration
7. 11197887 - Proton-binding polymers for oral administration
8. 10934380 - Crosslinked poly(allylamine) polymer pharmaceutical compositions
9. 10905711 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
10. 10570225 - Process for converting a polymeric ester to a polymeric acid
11. 10391118 - Proton-binding polymers for oral administration
12. 10369169 - Proton-binding polymers for oral administration
13. 10363268 - Proton-binding polymers for oral administration
14. 10272103 - Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants
15. 10058567 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal